Preclinical evaluation of tridecaptin M: <i>in vitro</i> and <i>in vivo</i> efficacy against colistin-resistant Gram-negative bacterial pathogens and pharmacokinetics
Vrushali Raka(Institute of Microbial Technology), Hemraj Nandanwar(Institute of Microbial Technology), Archana Angrup(Institute of Post Graduate Medical Education and Research), Rajneesh Dadwal(Institute of Microbial Technology), Manoj Jangra(Discovery Centre), Pallab Ray(Institute of Post Graduate Medical Education and Research), Parminder Kaur(Institute of Microbial Technology), Shubhangi Kansal(Institute of Post Graduate Medical Education and Research)
Cited by 0
Related Papers
A Microbe-Derived Efflux Pump Inhibitor of the Resistance-Nodulation-Cell Division Protein Restores Antibiotic Susceptibility in <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>
|ACS Infectious Diseases|2022|54
Pacemakers charging using body energy
|Journal of Pharmacy And Bioallied Sciences|2010|49
Alliance of Efflux Pumps with β-Lactamases in Multidrug-Resistant <i>Klebsiella pneumoniae</i> Isolates
|Microbial Drug Resistance|2019|48
Tridecaptin M, a New Variant Discovered in Mud Bacterium, Shows Activity against Colistin- and Extremely Drug-Resistant <i>Enterobacteriaceae</i>
|Antimicrobial Agents and Chemotherapy|2019|43